Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 4/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30410125 | 0.90 | LMNA (0.39) | DNM1TSHRFDPSLMNA | |
| SCHEMBL16287681 | 0.89 | — | — | |
| SCHEMBL31046789 | 0.87 | DNM1 (0.46) | DNM1TSHRLMNA | |
| SCHEMBL231722 | 0.84 | — | — | |
| SCHEMBL15846964 | 0.84 | LMNA (0.42) | DNM1TSHRFDPSLMNA | |
| SCHEMBL324656 | 0.84 | LMNA (0.42) | DNM1TSHRFDPSLMNA | |
| SCHEMBL15846767 | 0.84 | LMNA (0.42) | DNM1TSHRFDPSLMNA | |
| SCHEMBL14646603 | 0.81 | TSHR (0.39) | ALDH1A1TDP1TSHR | |
| SCHEMBL6683305 | 0.80 | — | — | |
| SCHEMBL22414459 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107074757-B | The manufacturing method of trifluoromethyl alkylthio chemical combination object | 组合化学工业株式会社 | 2019-05-03 | — | — | CN | disclosed |
| CN-107074757-A | The manufacture method of trifluoromethyl alkylthio compound | 组合化学工业株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-2813493-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | Sumitomo Chemical Company Limited (JP) | 2014-12-17 | — | — | EP | disclosed |
| EP-2067801-A1 | Synthesis of Hybrid Block Copolymers | Intezyne Technologies Incorporated (US) | 2009-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | ARG1, ACOT7, RPS8 | DNM1 2538/4885ALDH1A1 3183/4885TDP1 4640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.